Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.29 USD | -3.42% | -6.46% | -7.84% |
May. 22 | Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing | MT |
Apr. 22 | Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 14.95M | Capitalization | 476M |
---|---|---|---|---|---|
Net income 2024 * | -114M | Net income 2025 * | -111M | EV / Sales 2024 * | - |
Net cash position 2024 * | 218M | Net cash position 2025 * | 105M | EV / Sales 2025 * | 24.9 x |
P/E ratio 2024 * |
-3.72
x | P/E ratio 2025 * |
-4.68
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.86% |
Latest transcript on KalVista Pharmaceuticals, Inc.
1 day | -3.42% | ||
1 week | -6.46% | ||
Current month | -0.53% | ||
1 month | +0.71% | ||
3 months | -10.25% | ||
6 months | +48.94% | ||
Current year | -7.84% |
Managers | Title | Age | Since |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 04-03-25 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 16-07-31 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 21-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 19-01-31 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 16-07-31 |
Albert Cha
BRD | Director/Board Member | 51 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 2 M€ | -.--% | ||
0.03% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 11.29 | -3.42% | 548,928 |
24-05-22 | 11.69 | +0.69% | 368,322 |
24-05-21 | 11.61 | -2.27% | 432,719 |
24-05-20 | 11.88 | -0.34% | 379,115 |
24-05-17 | 11.92 | -1.24% | 337,564 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.84% | 493M | |
-2.15% | 89.22B | |
+1.32% | 40.49B | |
-15.73% | 32.79B | |
+64.13% | 26.23B | |
-21.28% | 14.52B | |
-8.50% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- KALV Stock